Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 Earnings Call Transcript January 28, 2026
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $0.96, expectations were $0.65.
Operator: Hello, and welcome to the Teva Pharmaceuticals Industries Limited Q4 2025 Earnings Conference Call. My name is Alex, and I’ll be coordinating today’s call. [Operator Instructions] I’ll now hand over to Chris Stevo, SVP, Investor Relations. Please go ahead.
Christopher...
